ID   MARK2_HUMAN             Reviewed;         788 AA.
AC   Q7KZI7; Q15449; Q15524; Q5XGA3; Q68A18; Q96HB3; Q96RG0;
DT   12-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 2.
DT   05-OCT-2010, entry version 78.
DE   RecName: Full=Serine/threonine-protein kinase MARK2;
DE            EC=2.7.11.1;
DE   AltName: Full=ELKL motif kinase 1;
DE            Short=EMK-1;
DE   AltName: Full=MAP/microtubule affinity-regulating kinase 2;
DE   AltName: Full=PAR1 homolog;
GN   Name=MARK2; Synonyms=EMK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Colon;
RX   MEDLINE=98399868; PubMed=9730619;
RA   Espinosa L., Navarro E.;
RT   "Human serine/threonine protein kinase EMK1: genome structure and cDNA
RT   cloning of isoforms produced by alternative splicing.";
RL   Cytogenet. Cell Genet. 81:278-282(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-208, AND MUTAGENESIS OF THR-208.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Kidney;
RA   Sugiyama A., Inoue H., Oka M.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 11-755 (ISOFORM 1).
RC   TISSUE=Kidney, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 28-788 (ISOFORM 4).
RX   MEDLINE=21326471; PubMed=11433294; DOI=10.1038/35083016;
RA   Sun T.-Q., Lu B., Feng J.-J., Reinhard C., Jan Y.N., Fantl W.J.,
RA   Williams L.T.;
RT   "PAR-1 is a Dishevelled-associated kinase and a positive regulator of
RT   Wnt signalling.";
RL   Nat. Cell Biol. 3:628-636(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 190-237.
RX   MEDLINE=94100173; PubMed=8274451;
RA   Schultz S.J., Nigg E.A.;
RT   "Identification of 21 novel human protein kinases, including 3 members
RT   of a family related to the cell cycle regulator nimA of Aspergillus
RT   nidulans.";
RL   Cell Growth Differ. 4:821-830(1993).
RN   [9]
RP   FUNCTION, AND ALTERNATIVE PROMOTER USAGE.
RX   PubMed=15158914; DOI=10.1016/j.bbadis.2004.01.008;
RA   Hueso M., Beltran V., Moreso F., Ciriero E., Fulladosa X.,
RA   Grinyo J.M., Seron D., Navarro E.;
RT   "Splicing alterations in human renal allografts: detection of a new
RT   splice variant of protein kinase Par1/Emk1 whose expression is
RT   associated with an increase of inflammation in protocol biopsies of
RT   transplanted patients.";
RL   Biochim. Biophys. Acta 1689:58-65(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=15365179; DOI=10.1073/pnas.0403684101;
RA   Cohen D., Rodriguez-Boulan E., Musch A.;
RT   "Par-1 promotes a hepatic mode of apical protein trafficking in MDCK
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13792-13797(2004).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-596,
RP   MUTAGENESIS OF THR-596, AND INTERACTION WITH YWHAZ.
RX   PubMed=15324659; DOI=10.1016/j.cub.2004.08.021;
RA   Suzuki A., Hirata M., Kamimura K., Maniwa R., Yamanaka T., Mizuno K.,
RA   Kishikawa M., Hirose H., Amano Y., Izumi N., Miwa Y., Ohno S.;
RT   "aPKC acts upstream of PAR-1b in both the establishment and
RT   maintenance of mammalian epithelial polarity.";
RL   Curr. Biol. 14:1425-1435(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; THR-208; SER-456;
RP   THR-469; SER-479; SER-486; SER-569; SER-571; SER-619 AND SER-631, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; THR-42; SER-456;
RP   SER-486; SER-569; SER-571; SER-576; SER-619 AND SER-621, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40; SER-43; SER-390;
RP   SER-409; SER-456; SER-483; SER-486; SER-493; SER-569; SER-619; SER-631
RP   AND THR-667, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409; SER-456 AND
RP   SER-569, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-40; THR-42;
RP   SER-43; SER-197; THR-208; SER-365; SER-390; SER-409; THR-419; SER-420;
RP   SER-422; TYR-423; SER-456; SER-471; SER-479; SER-486; SER-533;
RP   SER-569; SER-571; SER-619; SER-621; SER-631 AND SER-722, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-456 AND SER-571, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Role in epithelial morphogenesis. Modulates the
CC       developmental decision to build a columnar versus a hepatic
CC       epithelial cell apparently by promoting a switch from a direct to
CC       a transcytotic mode of apical protein delivery. Essential for the
CC       asymmetric development of membrane domains of polarized epithelial
CC       cells. One or more isoforms may play a role in graft rejection.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-208 by
CC       STK11 in complex with STE20-related adapter-alpha (STRAD alpha)
CC       pseudo kinase and CAB39.
CC   -!- INTERACTION:
CC       Q9BYG4:PARD6G; NbExp=1; IntAct=EBI-516560, EBI-295417;
CC       P63104:YWHAZ; NbExp=1; IntAct=EBI-516560, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
CC       Note=Phosphorylated by PRKCZ in polarized epithelial cells,
CC       resulting in an interaction with YWHAZ which promotes relocation
CC       from the lateral to the apical membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=14;
CC       Name=1;
CC         IsoId=Q7KZI7-1; Sequence=Displayed;
CC         Note=Produced by alternative promoter usage. No experimental
CC         confirmation available;
CC       Name=2;
CC         IsoId=Q7KZI7-2; Sequence=VSP_051705, VSP_051706;
CC         Note=Produced by alternative splicing of isoform 6;
CC       Name=3;
CC         IsoId=Q7KZI7-3; Sequence=VSP_051705, VSP_051707;
CC         Note=Produced by alternative splicing of isoform 6;
CC       Name=4; Synonyms=Par-1Balpha;
CC         IsoId=Q7KZI7-4; Sequence=VSP_051706, VSP_051707;
CC         Note=Produced by alternative splicing of isoform 1;
CC       Name=5;
CC         IsoId=Q7KZI7-5; Sequence=VSP_051706, VSP_051708;
CC         Note=Produced by alternative splicing of isoform 1;
CC       Name=6;
CC         IsoId=Q7KZI7-6; Sequence=VSP_051705;
CC         Note=Produced by alternative promoter usage. No experimental
CC         confirmation available;
CC       Name=7;
CC         IsoId=Q7KZI7-7; Sequence=VSP_051705, VSP_051706, VSP_051707;
CC         Note=Produced by alternative splicing of isoform 6. No
CC         experimental confirmation available;
CC       Name=8;
CC         IsoId=Q7KZI7-8; Sequence=VSP_051707;
CC         Note=Produced by alternative splicing of isoform 1. No
CC         experimental confirmation available;
CC       Name=9;
CC         IsoId=Q7KZI7-9; Sequence=VSP_051706;
CC         Note=Produced by alternative splicing of isoform 1. No
CC         experimental confirmation available;
CC       Name=10;
CC         IsoId=Q7KZI7-10; Sequence=VSP_051705, VSP_051706, VSP_051708;
CC         Note=Produced by alternative splicing of isoform 6. No
CC         experimental confirmation available;
CC       Name=11;
CC         IsoId=Q7KZI7-11; Sequence=VSP_051708;
CC         Note=Produced by alternative splicing of isoform 1. No
CC         experimental confirmation available;
CC       Name=12;
CC         IsoId=Q7KZI7-12; Sequence=VSP_051705, VSP_051708;
CC         Note=Produced by alternative splicing of isoform 6. No
CC         experimental confirmation available;
CC       Name=13;
CC         IsoId=Q7KZI7-13; Sequence=VSP_051705, VSP_039872, VSP_051706,
CC                                   VSP_051707;
CC         Note=Produced by alternative splicing of isoform 6;
CC       Name=14;
CC         IsoId=Q7KZI7-14; Sequence=VSP_051705, VSP_039872, VSP_051707;
CC         Note=Produced by alternative splicing of isoform 6;
CC   -!- TISSUE SPECIFICITY: High levels of expression in heart, brain,
CC       skeletal muscle and pancreas, lower levels observed in lung, liver
CC       and kidney.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. MARK subfamily.
CC   -!- SIMILARITY: Contains 1 KA1 (kinase-associated) domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 UBA domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK82368.1; Type=Erroneous initiation; Note=Translation N-terminally extended;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97630; CAA66229.1; -; mRNA.
DR   EMBL; AB188493; BAD37141.1; -; mRNA.
DR   EMBL; BT007342; AAP36006.1; -; mRNA.
DR   EMBL; U73647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008771; AAH08771.2; -; mRNA.
DR   EMBL; BC084540; AAH84540.1; -; mRNA.
DR   EMBL; AF387638; AAK82368.1; ALT_INIT; mRNA.
DR   EMBL; Z25427; CAA80914.1; -; mRNA.
DR   IPI; IPI00290158; -.
DR   IPI; IPI00335766; -.
DR   IPI; IPI00555696; -.
DR   IPI; IPI00555760; -.
DR   IPI; IPI00555838; -.
DR   IPI; IPI00556171; -.
DR   IPI; IPI00556187; -.
DR   IPI; IPI00556468; -.
DR   IPI; IPI00556593; -.
DR   IPI; IPI00556620; -.
DR   IPI; IPI00556650; -.
DR   IPI; IPI00718858; -.
DR   PIR; G01025; G01025.
DR   PIR; I38217; I38217.
DR   RefSeq; NP_001034558.2; -.
DR   RefSeq; NP_001156768.1; -.
DR   RefSeq; NP_001156769.1; -.
DR   RefSeq; NP_004945.4; -.
DR   RefSeq; NP_059672.2; -.
DR   UniGene; Hs.567261; -.
DR   PDB; 3IEC; X-ray; 2.20 A; A/B/C/D=49-363.
DR   PDBsum; 3IEC; -.
DR   ProteinModelPortal; Q7KZI7; -.
DR   SMR; Q7KZI7; 49-363, 692-788.
DR   DIP; DIP-31321N; -.
DR   IntAct; Q7KZI7; 40.
DR   MINT; MINT-1149196; -.
DR   STRING; Q7KZI7; -.
DR   PhosphoSite; Q7KZI7; -.
DR   PRIDE; Q7KZI7; -.
DR   Ensembl; ENST00000402010; ENSP00000385751; ENSG00000072518.
DR   GeneID; 2011; -.
DR   KEGG; hsa:2011; -.
DR   UCSC; uc001nxv.2; human.
DR   UCSC; uc001nxw.1; human.
DR   UCSC; uc001nxx.1; human.
DR   UCSC; uc001nxz.2; human.
DR   UCSC; uc001nya.2; human.
DR   UCSC; uc001nyb.1; human.
DR   CTD; 2011; -.
DR   GeneCards; GC11P063606; -.
DR   HGNC; HGNC:3332; MARK2.
DR   MIM; 600526; gene.
DR   PharmGKB; PA35047; -.
DR   eggNOG; prNOG17287; -.
DR   HOVERGEN; HBG052453; -.
DR   InParanoid; Q7KZI7; -.
DR   PhylomeDB; Q7KZI7; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 8141; -.
DR   ArrayExpress; Q7KZI7; -.
DR   Bgee; Q7KZI7; -.
DR   CleanEx; HS_MARK2; -.
DR   Genevestigator; Q7KZI7; -.
DR   GermOnline; ENSG00000072518; Homo sapiens.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial ...; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEP:BHF-UCL.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR001772; Kinase-assoc_KA1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020670; MAP/microtub-affin-reg_kin2/4.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015940; UBA/transl_elong_EF1B_N_euk.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF55; MAP/microtub-affin-reg_kin2/4; 1.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   ATP-binding; Cell membrane; Complete proteome; Developmental protein;
KW   Differentiation; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    788       Serine/threonine-protein kinase MARK2.
FT                                /FTId=PRO_0000086301.
FT   DOMAIN       53    304       Protein kinase.
FT   DOMAIN      323    362       UBA.
FT   DOMAIN      739    788       KA1.
FT   NP_BIND      59     67       ATP (By similarity).
FT   ACT_SITE    175    175       Proton acceptor (By similarity).
FT   BINDING      82     82       ATP (By similarity).
FT   MOD_RES      29     29       Phosphoserine.
FT   MOD_RES      40     40       Phosphoserine.
FT   MOD_RES      42     42       Phosphothreonine.
FT   MOD_RES      43     43       Phosphoserine.
FT   MOD_RES     197    197       Phosphoserine.
FT   MOD_RES     208    208       Phosphothreonine.
FT   MOD_RES     212    212       Phosphoserine (By similarity).
FT   MOD_RES     365    365       Phosphoserine.
FT   MOD_RES     390    390       Phosphoserine.
FT   MOD_RES     409    409       Phosphoserine.
FT   MOD_RES     419    419       Phosphothreonine.
FT   MOD_RES     420    420       Phosphoserine.
FT   MOD_RES     422    422       Phosphoserine.
FT   MOD_RES     423    423       Phosphotyrosine.
FT   MOD_RES     456    456       Phosphoserine.
FT   MOD_RES     469    469       Phosphothreonine.
FT   MOD_RES     471    471       Phosphoserine.
FT   MOD_RES     479    479       Phosphoserine.
FT   MOD_RES     483    483       Phosphoserine.
FT   MOD_RES     486    486       Phosphoserine.
FT   MOD_RES     493    493       Phosphoserine.
FT   MOD_RES     533    533       Phosphoserine.
FT   MOD_RES     569    569       Phosphoserine.
FT   MOD_RES     571    571       Phosphoserine.
FT   MOD_RES     576    576       Phosphoserine.
FT   MOD_RES     595    595       Phosphoserine (By similarity).
FT   MOD_RES     596    596       Phosphothreonine; by PKC/PRKCZ.
FT   MOD_RES     619    619       Phosphoserine.
FT   MOD_RES     621    621       Phosphoserine.
FT   MOD_RES     631    631       Phosphoserine.
FT   MOD_RES     667    667       Phosphothreonine.
FT   MOD_RES     722    722       Phosphoserine.
FT   VAR_SEQ       1     33       Missing (in isoform 2, isoform 3, isoform
FT                                6, isoform 7, isoform 10, isoform 12,
FT                                isoform 13 and isoform 14).
FT                                /FTId=VSP_051705.
FT   VAR_SEQ     412    412       Missing (in isoform 13 and isoform 14).
FT                                /FTId=VSP_039872.
FT   VAR_SEQ     505    558       Missing (in isoform 2, isoform 4, isoform
FT                                5, isoform 7, isoform 9, isoform 10 and
FT                                isoform 13).
FT                                /FTId=VSP_051706.
FT   VAR_SEQ     644    652       Missing (in isoform 3, isoform 4, isoform
FT                                7, isoform 8, isoform 13 and isoform 14).
FT                                /FTId=VSP_051707.
FT   VAR_SEQ     654    668       Missing (in isoform 5, isoform 11,
FT                                isoform 10 and isoform 12).
FT                                /FTId=VSP_051708.
FT   MUTAGEN     208    208       T->A: Prevents phosphorylation and
FT                                activation by STK11 complex.
FT   MUTAGEN     596    596       T->A: Loss of membrane dissociation and
FT                                binding to YWHAZ.
FT   CONFLICT    192    192       A -> G (in Ref. 8; CAA80914).
FT   CONFLICT    236    236       L -> C (in Ref. 8; CAA80914).
FT   CONFLICT    389    390       PS -> QF (in Ref. 1; CAA66229).
SQ   SEQUENCE   788 AA;  87911 MW;  F307BF4DDB543A70 CRC64;
     MSSARTPLPT LNERDTEQPT LGHLDSKPSS KSNMIRGRNS ATSADEQPHI GNYRLLKTIG
     KGNFAKVKLA RHILTGKEVA VKIIDKTQLN SSSLQKLFRE VRIMKVLNHP NIVKLFEVIE
     TEKTLYLVME YASGGEVFDY LVAHGRMKEK EARAKFRQIV SAVQYCHQKF IVHRDLKAEN
     LLLDADMNIK IADFGFSNEF TFGNKLDTFC GSPPYAAPEL FQGKKYDGPE VDVWSLGVIL
     YTLVSGSLPF DGQNLKELRE RVLRGKYRIP FYMSTDCENL LKKFLILNPS KRGTLEQIMK
     DRWMNVGHED DELKPYVEPL PDYKDPRRTE LMVSMGYTRE EIQDSLVGQR YNEVMATYLL
     LGYKSSELEG DTITLKPRPS ADLTNSSAPS PSHKVQRSVS ANPKQRRFSD QAAGPAIPTS
     NSYSKKTQSN NAENKRPEED RESGRKASST AKVPASPLPG LERKKTTPTP STNSVLSTST
     NRSRNSPLLE RASLGQASIQ NGKDSLTMPG SRASTASASA AVSAARPRQH QKSMSASVHP
     NKASGLPPTE SNCEVPRPST APQRVPVASP SAHNISSSGG APDRTNFPRG VSSRSTFHAG
     QLRQVRDQQN LPYGVTPASP SGHSQGRRGA SGSIFSKFTS KFVRRNLSFR FARRNLNEPE
     SKDRVETLRP HVVGSGGNDK EKEEFREAKP RSLRFTWSMK TTSSMEPNEM MREIRKVLDA
     NSCQSELHEK YMLLCMHGTP GHEDFVQWEM EVCKLPRLSL NGVRFKRISG TSMAFKNIAS
     KIANELKL
//
